1. Home
  2. EU vs MRVI Comparison

EU vs MRVI Comparison

Compare EU & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$2.13

Market Cap

353.5M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.40

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EU
MRVI
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.5M
472.8M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
EU
MRVI
Price
$2.13
$3.40
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$4.00
$4.13
AVG Volume (30 Days)
2.3M
1.9M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
14.29
EPS
N/A
N/A
Revenue
$43,155,000.00
$185,743,000.00
Revenue This Year
$212.11
$12.44
Revenue Next Year
$29.88
$7.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.70
52 Week High
$4.19
$4.11

Technical Indicators

Market Signals
Indicator
EU
MRVI
Relative Strength Index (RSI) 57.94 60.33
Support Level $2.06 $3.25
Resistance Level $2.17 $3.99
Average True Range (ATR) 0.13 0.17
MACD 0.06 0.07
Stochastic Oscillator 96.81 81.08

Price Performance

Historical Comparison
EU
MRVI

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: